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Abstract
G-protein-coupled receptors (GPCRs) regulate a wide variety of physiological processes and are important pharmaceutical
targets for drug discovery. Here, we describe a unique concept based on yeast cell-surface display technology to selectively
track eligible peptides with agonistic activity for human GPCRs (Cell Wall Trapping of Autocrine Peptides (CWTrAP) strategy).
In our strategy, individual recombinant yeast cells are able to report autocrine-positive activity for human GPCRs by
expressing a candidate peptide fused to an anchoring motif. Following expression and activation, yeast cells trap autocrine
peptides onto their cell walls. Because captured peptides are incapable of diffusion, they have no impact on surrounding
yeast cells that express the target human GPCR and non-signaling peptides. Therefore, individual yeast cells can assemble
the autonomous signaling complex and allow single-cell screening of a yeast population. Our strategy may be applied to
identify eligible peptides with agonistic activity for target human GPCRs.
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Introduction
G-protein-coupled receptors (GPCRs) constitute a large super-
family of cell surface receptors [1]. In humans, these 7-trans-
membrane proteins respond to external stimuli to regulate various
cellular processes including taste, smell, vision, heart rate, blood
pressure, neurotransmission and cell growth [2]. All members of
the guanine nucleotide binding protein family (G-proteins) share
a common mechanism for signal transmission following GPCR-
agonist binding [3]. This universal signaling mechanism has
become a central tenet in G-protein research, and GPCRs have
become major pharmaceutical targets for drug discovery [4].
The eukaryotic unicellular yeast, Saccharomyces cerevisiae, also
shares the G-protein-mediated signal transmission mechanism
with higher mammalian cells [3]. It is notable that S. cerevisiae offers
a crucial advantage to simplify the study of GPCR signaling
because it expresses only one kind of G-protein, which thereby
avoids potential problems such as signaling cross-talk in mamma-
lian cells [5–8]. Therefore, S. cerevisiae is a suitable host cell for the
screening of functional residues in GPCRs [5,9,10].
Yeast cell-surface display technology is a powerful platform that
enables proteins expressed in yeast to be tethered onto the cell
surface [11–15]. This is accomplished by the use of ‘‘anchor’’
proteins that naturally localize on the cell surface in yeast cells.
Typically, the gene encoding the target protein is fused to the
anchor protein together with a secretion signal sequence at the N-
terminus to both enable secretion of the fusion protein and to
tether it firmly to the cell surface. As typical anchor proteins, the
C-terminal domains of truncated a-agglutinin (Sag1p; a manno-
protein involved in sexual adhesion) and truncated Flo1p (a lectin-
like cell-wall protein involved in flocculation) containing the
glycosyl-phosphatidylinositol (GPI) anchor attachment signal
sequence at the C-terminus are fused to the target protein at
their N-termini [16,17]. Regarding other anchor proteins, the
Flo1p flocculation functional domain without the GPI anchor
attachment signal (FS anchor) permits the fusion of the target
protein to both its N- and C-termini [18]. These anchor proteins
are used to display the target proteins on the yeast cell wall. In
contrast, periplasmic invertase (Suc2 anchor) can be fused to both
the N- and C-termini of a target protein, enabling it to localize
into the periplasmic space [19]. To date, yeast cell-surface display
technology has been adopted for a broad range of applications
including enzymatic catalysis, immune adsorption and protein
engineering [16–18,20–23].
Here, we describe a unique concept using yeast cell-surface
display technology to selectively track eligible peptides that present
agonistic activity for human GPCRs. In our system, individual
yeast cells expressing human GPCRs fulfill a series of roles from
the manufacture of peptides to the sensing of agonistic activity.
Briefly, yeast cells synthesize candidate peptides in fusion with
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peptides are capable of binding cell surface GPCRs that transduce
the signal into the cell. Finally, the yeast traps the signaling peptide
on its cell wall (Figure 1). Here, we use a yeast strain that is
engineered to express a green fluorescent protein (GFP) reporter
gene in response to GPCR activation. Therefore, stimulation by
agonistic peptides can be recognized by the generation of a green
fluorescence signal [3]. In principle, because signaling peptides are
unable to diffuse to surrounding cells, our strategy has the
potential to build autonomous signaling complexes on a cell-by-
cell basis. Our peptide trapping method (cell wall trapping of
autocrine peptides (CWTrAP) system) will allow the identification
of lead peptides from combinatorial peptide libraries as starting
points for drug screening.
Results and Discussion
To corroborate the viability of cell-surface display technology to
track agonistic activity for GPCRs (CWTrAP system), we used a-
factor pheromone, a natural ligand for the endogenous yeast 7-
transmembrane GPCR, Ste2, which is specifically expressed in the
a-type-strain [24]. In nature, a-type yeast strains secrete a-factor
to induce mating signal transduction in the a-type strain by
binding to the Ste2 receptor on its cell surface [25]. The ability of
several types of protein motifs to anchor and transduce the
autocrine a-factor were tested in the recombinant a-type yeast
cells, which can express a GFP reporter gene in response to
pheromone signaling (Figure 1). All constructs of fusion proteins
that displayed a-factor peptides were designed to contain a Flag
tag between the a-factor peptides and anchor proteins (Figure 2A
and Table 1).
We used the IMG-4 yeast strain to display a-factor pheromone
on its cell surface because this strain can monitor signaling levels
through its endogenous Ste2 receptor via a GFP reporter gene
(Table 1). To test our concept, we evaluated the C-terminal 320 aa
of Sag1p (C-terminal half of a-agglutinin; AG) [16] and various
lengths of truncated Flo1p derivatives (C-terminal 42, 102, 146
and 318 aa of Flo1p; Flo42, Flo102, Flo146 and Flo318) [17] as
anchor proteins with GPI anchoring motifs (Figure 2A and
Table 1). A recombinant yeast strain, engineered to express the a-
factor autocrine peptide with a secretion signal sequence but
lacking an anchor motif, robustly generated a higher green
fluorescence signal than a strain harboring a mock plasmid
(Figure 3A, Mock and Sec). Immunofluorescence staining of Flag-
tagged a-factor peptide revealed no fluorescence on the surface of
engineered yeast cells (Figure 3B, Sec). These results suggest that
secreted a-factor could bind the endogenous Ste2 receptor and
transduce the signal inside the yeast cells.
Next, we tested the cell wall trapping (CWTrAP) strategy for a-
factor peptide with GPI anchoring motifs. All engineered yeast
strains expressing a-factor peptides fused to the N-termini of the
anchor proteins (AG and Flo42–318) with an inserted Flag tag
(Figure 2A) successfully generated a green fluorescence signal
(Figure 3A), confirming that the fusion peptide is able to activate
signal transduction in yeast. Using GFP fluorescence intensity as
an indicator of signaling strength, shorter anchor peptides
appeared more capable of activating the GPCR (Figure 3A).
The a-factor peptide fused to Flag and Flo42 exhibited higher
responsiveness compared to a-factor lacking the anchor protein.
This interesting result may arise from the transient enrichment of
the GPI-anchored peptide on the yeast cell membrane, although
the GPI-anchored peptide should be cleaved from the plasma
membrane by phosphatidylinositol-specific phospholipase C (PI-
PLC) and tethered on the cell wall [11–13].
Although shorter peptides tend to make detection of the Flag tag
more difficult, due to the report that shorter peptides can bury the
tag within the cell wall [17], we were able to confirm an anchor-
dependent association with the yeast cell wall by immunofluores-
Figure 1. Schematic illustration of our concept using yeast cell-surface display technology to selectively track eligible agonistic
peptides for human GPCRs by assembling the autonomous signaling complex within individual cells (cell wall trapping of
autocrine peptides (CWTrAP) strategy). The candidate autocrine peptides fused with the anchoring proteins are processed via secretion
pathways in engineered yeast cells. Their agonistic activities for heterologously-expressed human GPCRs are discerned on yeast cell membranes. Only
when the peptide possesses objective agonistic activity, membrane-peripheral G-proteins promote intracellular signaling and induce transcription of
the GFP reporter gene. Because the autocrine peptides are automatically trapped onto individual yeast cell walls, the captured peptides are unable to
diffuse toward surrounding yeast cells that express the target human GPCR and any other peptides. T.F. indicates transcription factor.
doi:10.1371/journal.pone.0037136.g001
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wall are unable to diffuse to surrounding cells, this result
emphasizes the viability of our concept for the assembly of the
autonomous signaling complex within individual yeast cells.
Additionally, we verified that a subset of Flo42 was highly
glycosylated (Figure S1); however, the agonistic activity of the a-
factor peptide was unlikely to be affected by the posttranslational
glycosylation of the anchor protein.
Next, we tested additional motifs that permit peptides to be
fused to both the N- and C-termini of the anchor proteins. We
replaced the GPI anchor proteins with the FS anchor [18] and the
Suc2 anchor [19] (Figure 2A, Table S2 and Document S1). Signal
transduction was more efficient when using the FS anchor,
compared to the Suc2 anchor (Figure S2). These results show that
agonistic peptides can be fused to both the N- and C-termini of
anchor proteins. Even though the FS anchor (1099 aa) served as
an efficient motif for transducing a-factor peptide signaling, we
used the Flo42 anchor motif, whose molecular mass is much lower
(Figure 2A), in all following experiments in order to minimize the
possibility of steric hindrance.
To further demonstrate the viability of our concept, the IMFD-
70 yeast strain, which can monitor signaling levels from
recombinantly expressed heterologous GPCRs by a GFP reporter
gene [5] (Table 1), was used to test if signal transmission from
human GPCRs expressed on the yeast cell surface was possible.
For these experiments, human somatostatin receptor subtype 5
(SSTR5), and the natural intramolecular-cross-linked cyclic
peptide ligand, somatostatin 14 (S-14), were used [26,27].
To express the autocrine somatostatin and trap it on the yeast
cell wall, we designed the S-14 peptide with an N-terminal
secretion signal sequence and a C-terminal Flo42 anchor protein
with a Flag tag (Figure 2B and Table 1). We constructed several
negative controls by eliminating the S-14 peptide or by replacing it
with agonistic peptides for other GPCRs (Figure 2B and Table 1).
We expressed hemagglutinin (HA)-tagged human SSTR5 on the
yeast cell surface using previously reported plasmids [5,6] (Table 1).
We used these expression and mock plasmids to investigate the
ability of the S-14–Flag–Flo42 autocrine peptide to activate
GPCR signaling (Figure 4).
As shown in Figure 4A, the engineered yeast strain concom-
itantly expressing SSTR5–HA and S-14–Flag–Flo42 successfully
induced GFP reporter gene expression, whereas the other control
strains possessing either SSTR5–HA or S-14–Flag–Flo42 did not.
Similarly, a control strain expressing SSTR5–HA and the
autocrine Flag–Flo42 fusion protein lacking the S-14 peptide
was unable to express a green fluorescence signal (Figure 4A).
Figure 2. Schematic illustration of the fusion protein constructs used to display agonistic peptides on the yeast cell-surface. (A)
Constructs for displaying a-factor peptides. AG: C-terminal half of a-agglutinin anchor. s.s.: secretion signal sequence. The pre-pro-region derived
from a-factor was used as s.s. For the fusion of FS and Suc2 anchors to the a-factor peptides at their C-termini, the original s.s. encoded in the N-
termini of Flo1p or Suc2p were used, respectively. The uppermost construct for secretion of a-factor peptide contains no anchoring motifs. All
constructs contain the Flag tag. (B) Constructs for displaying S-14 by the Flo42 anchor. The upper construct displaying only Flag and Flo42 peptides
was used as a negative control for the SSTR5 signaling assay. The middle and lower constructs displaying, respectively, eligible peptide (S-14) and
negative control peptides (a-factor, AII and ET1) by Flag–Flo42 fusion proteins were also used for the SSTR5 signaling assay.
doi:10.1371/journal.pone.0037136.g002
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nant SSTR5 by binding of the S-14 peptide fused to the Flo42
anchor mediates pheromone signaling via endogenous peripheral
G-proteins in yeast [5]. Furthermore, we were able to confirm the
specificity of the S-14 peptide because three control peptides in
which the S-14 peptide was replaced with the yeast Ste2 receptor
agonist, a-factor, the human angiotensin receptor agonist,
angiotensin II (AII), or the human endothelin receptor agonist,
endothelin-1 (ET1), did not generate a green fluorescence signal
(Figure 4B).
We confirmed the expression of SSTR5–HA receptor and S-
14–Flag–Flo42 fusion protein by western blot analysis (Figure 5).
Equal loading of the sodium lauryl sulfate (SDS)-extracted cell
lysate fraction from each pellet was confirmed using anti-b-actin.
SSTR5–HA receptor (anti-HA; lanes 2–4) and Flag–Flo42 anchor
or S-14–Flag–Flo42 fusion proteins (anti-Flag; lanes 3–5) were
successfully detected in the extracts of each appropriate transfor-
mant. The two unequal bands detected by the anti-Flag antibody
in the Flag–Flo42 and S-14–Flag–Flo42 transformants likely
represent the signal-cleaved and -uncleaved proteins, because the
pre-pro-region derived from a-factor was used as the secretion
signal sequence. We therefore tested the ability of the other active
somatostatin isoform S-28 [26] and other secretion signal
sequences (pre-region of a-factor and signal sequences derived
from S. cerevisiae Suc2p and Rhizopus oryzae glucoamylase) to
mediate signal transduction in the IMG-50 yeast strain. This strain
has a slightly different genetic background to IMFD-70 (FAR1-
intact strain [28], the description of the far1D allele can be found in
Materials and Methods; Table 1), but the expression profiles of the
GFP reporter genes remained essentially unchanged (Figure S3).
Also, the insertion of GS linkers (GGGGS and GGGSGGGGS)
between the S-14 peptide and Flag–Flo42 did not improve GFP
expression (Figure S4). Because GPCR signaling has been
reported to decrease plasmid retention even in the far1D yeast
strain [28], false-negative signals (non-signaling cell cluster;
Figure 4A, SSTR5–HA/S-14–Flag–Flo42) may be caused by
plasmid loss. Because other secretion signal sequences and the
insertion of GS linkers had no effect on expression of the GFP
reporter gene, it is unlikely that a false-negative signal would be
caused by steric hindrance of the S-14 peptide (Figure S3 and S4).
Nevertheless, the presence of false-negative cells within an
identical cell cluster implies that peptides captured on the cell
wall have little influence on the surrounding cells (Figure 4, S3 and
S4). Therefore, we demonstrated that peptides captured on the cell
wall did not induce false-positive signals in surrounding non-target
cells, even when two types of cells, one expressing the S-14–Flag–
Flo42 (target cells) and the other expressing the Flag–Flo42 anchor
lacking S-14 (non-target cells or surrounding cells), were mixed
(Figure S5). Additionally, we successfully enhanced the weaker
green fluorescence signal of the IMFD-70 strain expressing
SSTR5–HA and S-14–Flag–Flo42 (Figure 4A) by concurrently
introducing a multi-copy plasmid harboring the GFP reporter gene
Table 1. Yeast strains and plasmids used in this study.
Strain or plasmid Relative feature Source
Yeast strain
BY4741 MATa his3D1 leu2D0 met15D0 ura3D0 [31]
IMG-4 BY4741 fus1::FUS1-EGFP-TGAPDH-HIS3 bar1D::LEU2 far1D::kanMX4 This study
IMG-50 BY4741 fus1::FUS1-EGFP-TGAPDH-HIS3 sst2D::AUR1-C ste2D::LEU2 [28]
IMFD-70 BY4741 fig1D::EGFP his3D::PFIG1-EGFP far1D sst2D::AUR1-C ste2D::LEU2 [5]
Plasmid
pESC-URA
a Expression vector containing GAL1-GAL10 divergent promoter, 2m origin and URA3 marker Agilent Technologies
pUESCasf pESC-URA, a-factor–Flag peptide expression (for secretion) This study
pUESCaf-AG pESC-URA, a-factor–Flag–AG
b fusion protein expression (for display) This study
pUESCaf-FLO42 pESC-URA, a-factor–Flag–Flo42 fusion protein expression (for display) This study
pUESCaf-FLO102 pESC-URA, a-factor–Flag–Flo102 fusion protein expression (for display) This study
pUESCaf-FLO146 pESC-URA, a-factor–Flag–Flo146 fusion protein expression (for display) This study
pUESCaf-FLO318 pESC-URA, a-factor–Flag–Flo318 fusion protein expression (for display) This study
pGK421
a Expression vector containing PGK1 promoter, 2m origin and MET15 marker [5,6]
pGK-SSTR5-HA pGK421, SSTR5-HA human receptor expression [5,6]
pGK426
a Expression vector containing PGK1 promoter, 2m origin and URA3 marker [36]
pGK42 pGK426, Flag–Flo42 anchor protein expression (for display) This study
pGK-S1442 pGK426, S-14–Flag–Flo42
c fusion protein expression (for display) This study
pGK-alpha42 pGK426, a-factor–Flag–Flo42 fusion protein expression (for display) This study
pGK-AII42 pGK426, AII–Flag–Flo42
d fusion protein expression (for display) This study
pGK-ET142 pGK426, ET1–Flag–Flo42
e fusion protein expression (for display) This study
pMHG-FIG1 Multi-copy reporter plasmid containing FIG1 promoter, GFP reporter gene, 2m origin and HIS3 marker [6]
All transcription products for display or secretion contain the secretion signal sequence of a-factor.
aThe indicated vectors were used as mock controls.
bAG indicates C-terminal half of a-agglutinin anchor protein.
cS-14 encodes somatostatin 14 mature peptide.
dAII encodes angiotensin II mature peptide.
eET1 encodes endothelin-1 mature peptide.
doi:10.1371/journal.pone.0037136.t001
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support the feasibility of our conceptual CWTrAP system to
identify eligible agonistic peptides for human GPCRs.
Finally, to examine whether the yeast cell wall did indeed trap
the autocrine peptide fused to the Flo42 anchor, transformants
were analyzed by immunofluorescence staining with anti-Flag
primary antibody and Alexa Fluor 594 conjugated secondary
antibody (Figure 7). We observed red fluorescence on the cell
surfaces of appropriate transformants that expressed Flag–Flo42
anchor or S-14–Flag–Flo42 fusion proteins. In addition, we only
observed a morphology change [29] on cells expressing both
SSTR5–HA and S-14–Flag–Flo42, supporting our hypothesis that
the autocrine S-14 peptide specifically triggered signal trans-
duction via the SSTR5 receptor in the recombinant yeast cells.
Thus, we successfully verified that the S-14 autocrine peptide
fused to the Flo42 anchor protein was trapped on the yeast cell
wall.
In this study, we have demonstrated how a strategy for cell wall
trapping of autocrine peptides (CWTrAP system) functions to
discern agonistic activity for human GPCRs expressed in yeast
Figure 3. Evaluation of the CWTrAP system using a-factor peptide for yeast endogenous Ste2 receptor. (A) Pheromone signaling assays
of a-factor-displaying yeast strains. Error bars represent the standard deviation of three independent experiments. (B) Immunofluorescence staining
of a-factor displaying yeast strains. Anti-Flag antibody and Alexa Fluor 546-conjugated secondary antibody were used for detection of secreted a-
factor or a-factor-anchor fusion proteins. IMG-4 was used as the host strain. The transformants used in these experiments are listed in Table S3. Sec:
free, secreted form of a-factor. AG: C-terminal half of a-agglutinin anchor.
doi:10.1371/journal.pone.0037136.g003
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and its specific receptor as our model. Our motivation was to
selectively track eligible agonistic peptides for human GPCRs by
assembling an autonomous signaling complex within individual
cells. By combining cell-surface display technology and established
yeast combinatorial genetic engineering technology with flow
cytometric single-cell screening [30], we aim to identify eligible
peptides from peptide libraries. Here, the feasibility of our concept
is demonstrated by peptide capture, and subsequent signal
transduction, by heterologously-expressed human GPCRs, which
prevent the captured peptides from diffusing to surrounding yeast
cells and eliciting a false-positive response. Therefore, the captured




Synthetic raffinose (SR) media contained 6.7 g/l yeast nitrogen
base without amino acids (YNB) (BD-Diagnostic Systems, Sparks,
MD, USA) and 20 g/l raffinose. For SRGC media, 20 g/l
galactose and 20 g/l casamino acids (BD-Diagnostic Systems)
were added into SR media. Synthetic dextrose (SD) media
contained 6.7 g/l YNB and 20 g/l glucose. For SDM71 media,
SD media was adjusted to pH 7.1 with 200 mM MOPSO buffer
(Nacalai Tesque, Kyoto, Japan). Amino acids and nucleotides
(20 mg/l histidine, 60 mg/l leucine, 20 mg/l methionine or
20 mg/l uracil) were supplemented into each medium to provide
the relevant auxotrophic components.
Figure 4. Evaluation of the CWTrAP system using somatostatin peptide for the human SSTR5 receptor. (A) SSTR5 signaling assays of the
cyclic somatostatin peptide displaying yeast strain and control strains. (B) SSTR5 signaling assays of non-target peptide displaying yeast strains. IMFD-
70 was used as the host strain. The transformants used in these experiments are listed in Table S3. S-14 indicates 14 aa of somatostatin cyclic peptide,
a-factor indicates 13 aa of yeast pheromone peptide, AII indicates 8 aa of angiotensin II peptide, and ET1 indicates 21 aa of endothelin-1 peptide.
doi:10.1371/journal.pone.0037136.g004
Cell Wall Trapping of Autocrine Peptides (CWTrAP)
PLoS ONE | www.plosone.org 6 May 2012 | Volume 7 | Issue 5 | e37136Yeast Strains
Yeast strains used for assays were generated from BY4741 [31]
as a parental backbone strain and are listed in Table 1. The
transformation procedure using linear DNA fragments followed
the lithium acetate method [32]. All primers used for the strain
constructions are listed in Table S1. The bar1D alleles that relieve
the degradation of a-factor pheromone [33] were conferred to
BY4741far1D (obtained from Saccharomyces Genome Deletion
Project [34]) by homologous recombination with the amplified
LEU2 fragments, producing the IM-4 strain. The FUS1-GFP
reporter gene was integrated into the FUS1 genomic loci of IM-4
with a fragment prepared by digestion of pUC119-FUS1-EGFP-
HIS3 [28] with EcoRI and SphI, producing the IMG-4 strain.
The PFUS1-FUS1-GFP or PFIG1-GFP reporter gene was used to
monitor signal transduction promoted by stimulating GPCRs in
yeast (IMG-4, IMG-50 or IMFD-70 [5]). far1D alleles were used
to avoid G1 arrest and promote cell-cycle progression during
signal activation [5,28,35] (IMG-4 and IMFD-70). sst2D and
ste2D alleles were used to obtain hypersensitivity for ligand
stimulation and to inhibit competitive expression of endogenous
yeast GPCRs [5,28] (IMG-50 and IMFD-70).
Plasmids
All plasmids used for assays are listed in Table 1. All primers
used for plasmid constructions are listed in Table S1. The
amplified pre, pro (containing secretion signal sequence, s.s.) and
first mature sequences of a-factor peptide including a C-terminal
Flag tag and stop codon were inserted into the pESC-URA yeast
expression vector (Agilent Technologies, Santa Clara, CA, USA)
at the BamHI and XhoI sites, creating pUESCasf. As the
backbone for a-factor-displaying plasmids, pUESCaf and
pUESCaf(AG) without stop codons were constructed in essen-
tially the same manner. The amplified genes encoding Flo42,
Flo102, Flo146 and Flo318 anchors were inserted into pUESCaf
at the XhoI and NheI sites, resulting in pUESCaf-FLO42, -
FLO102, -FLO146 and -FLO318, respectively. pUESCaf-AG
was produced in a similar procedure by inserting the gene
encoding the C-terminal 320 aa of Sag1p (C-terminal half of a-
agglutinin anchor, AG) into pUESCaf(AG) at the XhoI and
NheI sites. As the backbone for somatostatin-displaying plasmids,
we constructed pGK426-tgFLO42 by inserting the amplified
FLO42 anchor gene with FLAG at the N-terminus into pGK426
at the SalI and BglII sites [36]. The DNA fragment containing
s.s. of a-factor and S-14 mature peptide was amplified by
overlapping PCR and inserted into pGK426-tgFLO42 at the
NheI and SalI sites, producing pGK-S1442. We generated pGK-
alpha42 as an a-factor peptide-displaying control plasmid, using
essentially the same procedure. As other peptide-displaying
control plasmids, the gene containing s.s. of a-factor and the
mature peptide sequences of angiotensin II (AII) or endothelin-1
(ET1) was inserted into pGK426-tgFLO42 at the NheI and SalI
sites, generating pGK-AII42 and pGK-ET142, respectively. As
a peptide-non-displaying control plasmid, pGK42 was created in
a similar procedure by using the DNA fragment containing s.s. of
a-factor without the peptide sequence. pGK-SSTR5-HA [5,6]
was used to express human SSTR5 receptor fused to a C-
terminal HA tag. Transformation of plasmids was performed
using the lithium acetate method. All transformants used for
assays are listed in Table S3.
Pheromone Signaling Assay
To assay signal activation from the endogenous Ste2
pheromone receptor, the IMG-4 yeast strains harboring the
Figure 5. Confirmation of protein expression. Western blots of
extracts from somatostatin displaying yeast strains. Lane 1: Mock/Mock,
2: SSTR5/Mock, 3: SSTR5/Flag–Flo42, 4: SSTR5/S-14–Flag–Flo42, 5: Mock/
S-14–Flag–Flo42. Anti-b-actin antibody was used as loading control.
Anti-HA antibody was used for detection of SSTR5 receptor. Anti-Flag
antibody was used for detection of Flag–Flo42 anchor or S-14–Flag–
Flo42 fusion proteins. IMFD-70 was used as the host strain. The
transformants used in these experiments are listed in Table S3.
doi:10.1371/journal.pone.0037136.g005
Figure 6. Improved fluorescence signal in the CWTrAP system using somatostatin peptide for the human SSTR5 receptor. SSTR5
signaling assays of the cyclic somatostatin peptide displaying yeast strain and the non-displaying control strain, which contain the multi-copy
plasmid harboring a GFP reporter gene cassette (pMHG-FIG1). IMFD-70 was used as the host strain. The transformants used in these experiments are
listed in Table S3.
doi:10.1371/journal.pone.0037136.g006
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and cells were then inoculated into 100 ml of SRGC media to
give an initial optical density of 0.03 at 600 nm. Cultures were
grown at 30uC with shaking at 150 opm for 72 h. The cells were
collected and diluted into test tubes containing sheath solution
and GFP fluorescence was measured using a BD FACSCalibur
flow cytometer (BD Biosciences, San Jose, CA, USA). The green
fluorescence signal from 10,000 cells was excited with an argon
laser and collected through a 530/30 nm band-pass (FL1) filter.
The data were analyzed using BD CELLQuest software (BD
Biosciences). The ‘‘relative fluorescence unit’’ was defined using
the FL1-H geometric mean of IMG-4 harboring mock plasmid
(pESC-URA) as the benchmark.
SSTR5 Signaling Assay
To assay signal activation from human SSTR5 receptor, the
IMFD-70 yeast strains harboring the pGK-SSTR5-HA and
pGK426-based plasmids were grown in SD media at 30uC, and
cells were then inoculated into 20 ml of SDM71 media to give
an initial OD600 of 0.03. Cultures were grown at 30uC with
shaking at 150 opm for 15 h. The cells were collected and
diluted into test tubes containing sheath solution and GFP
fluorescence was measured using a BD FACSCanto II flow
cytometer (BD Biosciences). The green fluorescence signal from
10,000 cells was excited with a blue laser and collected through
a 530/30 nm band-pass (GFP) filter. The data were analyzed
using BD FACSDiva software (BD Biosciences).
Western Blotting
Collected cells were suspended in 10 mM Tris-HCl (pH 7.8)
containing 1 mM phenylmethylsulfonyl fluoride (PMSF) to give
an OD600 of 5, and 200 ml of cell suspension was disrupted using
a Multi-beads shocker (Yasui Kikai, Osaka, Japan) with 0.5 mm
glass beads. Cell lysates were centrifuged at 1,0006g for 5 min
and the pellet was then washed three times with 10 mM Tris-
HCl containing 1 mM PMSF. The pellet was resuspended in
200 ml of SDS solubilization buffer (50 mM Tris-HCl [pH 7.8],
2% SDS [w/v], 100 mM ethylene diamine tetraacetic acid
[EDTA], 40 mM 2-mercaptoethanol [2-ME]), and the suspen-
sion was boiled at 95uC for 5 min and then centrifuged at
10,0006g for 5 min. The supernatant was collected and diluted
with an equivalent volume of 26 sample buffer (25 mM Tris-
HCl [pH 6.8], 4% SDS [w/v], 20% glycerol [w/v], 10% 2-ME
[v/v], 0.1 mg/ml bromophenol blue [BPB]). Twenty microliters
of each sample was loaded onto a 12.5% SDS-polyacrylamide
gel and proteins were separated by electrophoresis and then
transferred to polyvinylidene fluoride (PVDF) membrane (Im-
mobilon-FL; Millipore, Billerica, MA, USA) by electroblotting.
Western blots were performed as follows: mouse anti-b-actin
monoclonal antibody (Abcam, Cambridge, UK) as loading
control, rabbit anti-HA antibody (Bethyl Laboratories, Mon-
tgomery, TX, USA) for HA-tagged SSTR5 receptor, and mouse
anti-Flag M2 monoclonal antibody (Sigma-Aldrich, St. Louis,
MO, USA) for fusion proteins with S-14 peptide, Flag tag and
Flo42 anchors were primarily used at dilutions of 1:5,000 in
TBST (10 mM Tris-HCl [pH 8.0], 150 mM NaCl, 0.05%
Tween-20 [v/v]). Anti-mouse or anti-rabbit secondary antibodies
conjugated with alkaline phosphatase (Promega, Madison, WI,
USA) were used at dilutions of 1:5,000 in TBST. Chemilumi-
nescent visualization was performed with Amersham CDP-Star
Detection Reagent (GE Healthcare, Buckinghamshire, UK) and
the signal was detected using a lumino-image analyzer LAS-
1000mini system (Fujifilm, Tokyo, Japan).
Figure 7. Confirmation of peptide trapping on yeast cell surfaces. Immunofluorescence staining of somatostatin displaying yeast strains.
Anti-Flag antibody and Alexa Fluor 594-conjugating secondary antibody were used for detection of Flag–Flo42 anchor or S-14–Flag–Flo42 fusion
proteins. Red fluorescence images are shown in false-color. IMFD-70 was used as the host strain. The transformants used in these experiments are
listed in Table S3.
doi:10.1371/journal.pone.0037136.g007
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For a-factor displaying yeasts (IMG-4), collected cells were
diluted to give an OD600=10 with distilled water and the cell
suspension was used for immunofluorescence staining by in-
cubating with mouse anti-Flag M2 monoclonal antibody (Sigma-
Aldrich) at a dilution of 1:500 for 1 h at room temperature. After
washing in triplicate, anti-mouse secondary antibody conjugated
with Alexa Fluor 546 (Invitrogen Life Technologies, Carlsbad,
CA, USA) at a dilution of 1:500 was incubated with the cell
suspensions for 1 h at room temperature. After washing in
triplicate, cells were resuspended in distilled water and observed
on a fluorescence microscope with a monochrome CCD camera.
To obtain micrographs of better clarity, essentially the same
procedure was used for somatostatin displaying yeasts (IMFD-70),
but the density of the collected cells was adjusted to OD600=5.
Antibodies were used at a dilution factor of 1:100. Anti-mouse IgG
conjugated with Alexa Fluor 594 (Invitrogen Life Technologies)
was used as the secondary antibody.
Supporting Information
Figure S1 Western blotting of SDS-extracted fractions
from the IMG-4/pUESCaf-FLO42 yeast strain. EndoHf
(Endoglycosidase H) was used to confirm glycosylation of the
Flo42 anchor. Anti-Flag M2 monoclonal antibody and anti-mouse
secondary antibody conjugated with alkaline phosphatase were
used to detect the a-factor–Flag–Flo42 fusion protein. NBT (nitro
blue tetrazolium) and BCIP (5-bromo-4-chloro-3-indolyl-phos-
phate) were used for the colorimetric reaction.
(TIF)
Figure S2 Pheromone signaling assays of a-factor-
displaying yeast strains with various anchor motifs
(color histograms). Gray histograms show the data from
control strains (mock). IMG-4 was used as the host strain. The
transformants used in this experiment are listed in Table S3.
(TIF)
Figure S3 SSTR5 signaling assays of somatostatin-
displaying yeast strains with various secretion signal
sequences (color histograms). The Flo42 anchor was used
for somatostatin display. S-28 indicates the 28 aa active isoform of
somatostatin peptide. Gray histograms show the data from control
strains (mock). Cultures were grown in SDM71 media for 22 h.
IMG-50 was used as the host strain. The transformants used in this
experiment are listed in Table S3.
(TIF)
Figure S4 SSTR5 signaling assays of somatostatin-
displaying yeast strains with different length GS linkers
(color histograms). The S-14 peptide and Flo42 anchor were
used for display. Gray histograms show the data from control
strains (mock). Cultures were grown in SDM71 media for 12 h.
IMG-50 was used as the host strain. The transformants used in this
experiment are listed in Table S3.
(TIF)
Figure S5 SSTR5 signaling assays of somatostatin-
displaying yeast strain (target cells) mixed with somato-
statin-non-displaying strain (non-target cells). S-14–Flag–
Flo42 and Flag–Flo42 fusion proteins were used as target and non-
target cells, respectively. R1 regions in the dot plots show the gates
for FACS sorting. The ratio of initial cell densities was adjusted to
10:1 (non-target cells : target cells), and the cultures were grown in
SDM71 media. IMG-50 was used as the host strain. The
transformants used in this experiment are listed in Table S3.
(TIF)
Table S1 List of primers.
(PDF)
Table S2 Plasmids used in Supplementary data.
(PDF)
Table S3 List of strains and transformants used for
assays.
(PDF)
Document S1 Supplementary Materials and Methods
(Plasmid constructions for supporting information).
(PDF)
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